Neuroblastoma cell lineage and immunotherapy responsiveness: a complicated relationship
dc.rights.license | CC-BY-NC-ND | |
dc.contributor.advisor | Nierkens, Stefan | |
dc.contributor.author | Dekker, Eva | |
dc.date.accessioned | 2023-03-22T01:00:52Z | |
dc.date.available | 2023-03-22T01:00:52Z | |
dc.date.issued | 2023 | |
dc.identifier.uri | https://studenttheses.uu.nl/handle/20.500.12932/43705 | |
dc.description.sponsorship | Utrecht University | |
dc.language.iso | EN | |
dc.subject | The plasticity of neuroblastoma mesenchymal (MES) and adrenergic cells and implications for responsiveness to therapy, particularly isotretinoin are explored. Possibilities for targeting MES cells using immunotherapy are described. | |
dc.title | Neuroblastoma cell lineage and immunotherapy responsiveness: a complicated relationship | |
dc.type.content | Master Thesis | |
dc.rights.accessrights | Open Access | |
dc.subject.keywords | Neuroblastoma; Immunotherapy; Isotretinoin; Mesenchymal; Adrenergic | |
dc.subject.courseuu | Biology of Disease | |
dc.thesis.id | 15148 |